Seven lessons from two candidate genes in human essential hypertension: Angiotensinogen and epithelial sodium channel

Hypertension

Volumn 33, Issue 6, 1999, Pages 1324-1331

  Corvol, Pierre ^a   Persu, Alexandre ^a   Gimenez Roqueplo, Anne Paule ^a   Jeunemaitre, Xavier ^a  

^a PSL Research University   (France)

Author keywords

Angiotensinogen; Blood pressure; Essential; Genetics; Hypertension; Sodium channel

Indexed keywords

ANGIOTENSIN; ANGIOTENSINOGEN; PROTEIN SUBUNIT; SODIUM CHANNEL;

ANTIHYPERTENSIVE THERAPY; CONFERENCE PAPER; DIET THERAPY; ESSENTIAL HYPERTENSION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC RISK; GENETIC VARIABILITY; HUMAN; KIDNEY BLOOD FLOW; LIDDLE SYNDROME; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; POPULATION RESEARCH; PRIORITY JOURNAL; STATISTICAL ANALYSIS;

EID: 0032979840     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.33.6.1324     Document Type: Conference Paper

References (68)

1. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel J-M. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature. 1992;355:262-265.
2. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hansson JH, Shambelan M, Gill JJ, Ulick S, Milora RV, Findling JW, Canessa C, Rossier BC, Lifton RP. Liddle's syndrome: Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell. 1994;79:407-414.
3. Mune T, Rogerson FM, Nikkila H, Agarwal AK, White PC. Human hypertension caused by mutations in the kidney isozyme of 11β-hydroxysteroid dehydrogenase. Nat Genet. 1995;10:394-399.
4. Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP. Multilocus linkage of familial hyperkalaemia and hypertension pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet. 1997;16:202-205.
5. Shuster H, Wienker TF, Bähring S, Bilginturan N, Toka HR, Neitzel H, Jeschke E, Tokan O, Gilbert D, Lowe A, Ott J, Haller H, Luft FC. Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet. 1996;13:98-100.
6. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel J-M, Corvol P. Molecular basis of human hypertension. Role of angiotensinogen. Cell. 1992;71:169-180.
7. Corvol P, Jeunemaitre X. Molecular genetics of human hypertension. Role of angiotensinogen. Endocr Rev. 1997;18:662-677.
8. Kotelevtsev YuV, Clauser E, Corvol P, Soubrier F. Dinucleotide repeat polymorphism in the human angiotensinogen gene. Nucleic Acids Res. 1991;19:6978.
9. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
10. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clark AJ. Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest. 1995;96:687-692.
11. Atwood LD, Kammerer CM, Samollow PB. Linkage of essential hypertension to the angiotensinogen locus in Mexican Americans. Hypertension. 1997;30:326-330.
12. Brand E, Chatelain N, Keavney B, Caulfield M, Citterio L, Connell J, Grobbee D, Schmidt S, Shunkert H, Schuster H, Sharma AM, Soubrier F. Evaluation of the angiotensinogen locus in human essential hypertension: a European study. Hypertension. 1998;31:725-729.
13. Niu T, Xu X, Rogus J, Zhou Y, Chen C, Wang J, Faug Z, Schmitz C, Zhao J, Rao VS, Lindpaintner K. Angiotensinogen gene and hypertension in Chinese. J Clin Invest. 1998;101:188-194.
14. Jeunemaitre X, Gimenez-Roqueplo A-P, Celerier J, Corvol P. Angiotensinogen variants and human hypertension. Cur Hypertens Rep. 1999;1: 31-41.
15. Kunz R, Kreutze R, Beige J, Distler A, Sharma A. Association between the angiotensinogen 235T variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension. 1997;30: 1331-1337.
16. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietinck R, Fagard R. M235T angiotensinogen polymorphism and cardiovascular renal risk. J Hypertens. 1999;17:9-17.
17. Inoue I, Rohrwasser A, Helin C, Jeunemaitre X, Crain P, Bohlender J, Lifton RP, Corvol P, Ward K, Lalouel J-M. A mutation of angiotensinogen in a patient with preeclampsia leads to altered kinetics of the renin angiotensin system. J Biol Chem. 1995;270:11430-11436.
18. Gimenez-Roqueplo A-P, Leconte I, Cohen P, Simon D, Guyene T-T, Celerier J, Pau B, Corvol P, Clauser E, Jeunemaitre X. The natural mutation Y248C of human angiotensinogen leads to abnormal glycosylation and altered immunological recognition of the protein. J Biol Chem. 1996;271:9838-9844.
19. Cohen P, Badouaille G, Gimenez-Roqueplo A-P, Mani JC, Guyene T-T, Jeunemaitre X, Ménard J, Corvol P, Pau B, Simon D. Selective recognition of M235T angiotensinogen variants and their determination in human plasma by monoclonal antibody-based immunoanalysis. J Clin Endocrinol Metab. 1996;81:3505-3512.
20. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo A-P, Hata A, Corvol P, Lalouel J-M. Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet. 1997;60:1448-1460.
21. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel J-M. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest. 1997;99:1786-1797.
22. Zhao YY, Zhon J, Narayanan CS, Cui Y, Kumar A. Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension. 1999;33:108-115.
23. Ishigami T, Umemura S, Tamura K. Essential hypertension and 5′ upstream core promoter region of human angiotensinogen gene. Hypertension. 1997;30:1325-1330.
24. Walker WG, Whelton PK, Saito H, Russel RP, Hermann J. Relation between blood pressure and renin, renin substrate, angiotensin II, aldosterone, and urinary sodium and potassium in 574 ambulatory subjects. Hypertension. 1979;1:287-291.
25. Fasola AF, Martz BL, Helmer OM. Plasma renin activity during supine exercise in offspring of hypertensive patients. J Appl Physiol. 1968;25: 410-415.
26. Jeunemaitre X, Charru A, Chatellier G, Dumont C, Sassano P, Soubrier F, Ménard J, Corvol P. M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens. 1993;11(suppl 5):S-80-S-81.
27. Bloem LJ, Manatunga AK, Tewksbury DA, Pratt JH. The serum angiotensinogen concentration and variants of the angiotensinogen gene in white and black children. J Clin Invest. 1995;95:948-953.
28. Bloem LJ, Foroud TM, Ambrosius WT, Hanna MP, Tewksbury DA, Pratt JH. An association of the angiotensinogen gene to serum angiotensinogen in blacks and whites. Hypertension. 1997;29:1078-1082.
29. Busjahn A, Knoblauch H, Knoblauch M, Bohlender J, Menz M, Faulhaber H-D, Becker A, Schuster H, Luft FC. Angiotensin-converting enzyme and angiotensinogen gene polymorphisms, plasma levels, cardiac dimensions: a twin study. Hypertension. 1997;29:165-170.
30. Schunkert H, Hense HW, Gimenez-Roqueplo A-P, Stieber J, Keil U, Riegger GAJ, Jeunemaitre X. The angiotensinogen T235 variant and the use of antihypertensive drugs in a population based-cohort. Hypertension. 1997;29:628-633.
31. Morgan T, Craven C, Nelson L, Lalouel JM, Ward K. Angiotensinogen T235 expression is elevated in decidual spiral arteries. J Clin Invest. 1997;100:1406-1415.
32. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel J-M. A molecular variant of angiotensinogen associated with preeclampsia. Nat Genet. 1993;4:59-61.
33. Arngrimsson R, Purandare S, Connor M, Walker JJ, Björnsson S, Soubrier F, Kotelevtsev YV, Geirsson RT, Björnsson H. Angiotensinogen: a candidate gene involved in preeclampsia? Nat Genet. 1993;4: 114-115.
34. Williams GH, Hollenberg NK. Non-modulating hypertension: a subset of sodium-sensitive hypertension. Hypertension. 1991;17(suppl I):I-81-1-85.
35. Williams GH, Dluhy RG, Lifton RP, Moore TJ, Gleason R, Williams RR, Hunt SC, Hopkins PN, Hollenberg NK. Non-modulation as an intermediate phenotype in essential hypertension. Hypertension. 1992;20: 788-796.
36. Hopkins PN, Lifton RP, Hollenberg NK, Jeunemaitre X, Hallouin M-C, Skuppin J, Williams CS, Dluhy RG, Lalouel J-M, Williams RR, Williams GH. Blunted renal vascular response to angiotensin II is associated with a common variant of the angiotensinogen gene and obesity. J Hypertens. 1996;14:199-207.
37. + channel. In: Narahashi T, ed. Ion Channels. New York, NY: Plenum; 1996:115-168.
38. Liddle GW, Bledsoe T, Coppage WS. A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Assoc Am Physicians. 1963;76:199-213.
39. Tamura H, Schild L, Enomoto N, Matsui N, Marumo F, Rossier BC. Liddle disease caused by a missense mutation of β subunit of the epithelial sodium channel gene. J Clin Invest. 1996;97:1780-1784.
40. Hansson JH, Schild L, Lu Y, Wilson TA, Gautschi I, Shimkets R, Nelson-Williams C, Rossier BC, Lifton RP. A de novo missense mutation of the β subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci U S A. 1995;92:11495-11499.
41. Jeunemaitre X, Bassilana F, Persu A, Dumont C, Champigny G, Lazdunski M, Corvol P, Barbry P. Genotype-phenotype analysis of a newly discovered family with Liddle's syndrome. J Hypertens. 1997;15: 1091-1100.
42. Melander O, Orho M, Fagerudd J, Bengtsson K, Groop PH, Mattiasson I, Groop L, Hulthen UL. Mutations and variants of the epithelial sodium channel gene in Liddle's syndrome and primary hypertension. Hypertension. 1998;31:1128-1124.
43. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets RA, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP. Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nat Genet. 1995;11:76-82.
44. + channel deleted in Liddle syndrome. EMBO J. 1996;15:2371-2380.
45. + channel by Nedd4 in Liddle's syndrome. J Clin Invest. 1999;103:667-673.
46. Baker E., Jeunemaitre X, Protal J, Grimbert P, Markandu N, Persu A, Corvol P, MacGregor G. Abnormalities of nasal potential difference measurement in Liddle's syndrome. J Clin Invest. 1998;102:10-14.
47. Luft FC, Grim CE, Higgins JC, Weinberger MD. Differences in response to Na administration in normotensive black and white subjects. J Lab Clin Med. 1977;90:555-562.
48. Su YR, Rutkowski MP, Klanke CA, Wu X, Cui Y, Pun RYK, Carter V, Reif M, Menon AG. A novel variant of the β-subunit of the amiloride-sensitive sodium channel in African-Americans. J Am Soc Nephrol. 1996;12:2543-2549.
49. + channel in essential hypertension. Hypertension. 1998;32: 129-137.
50. Baker EH, Dong YB, Sagnella GA, Rothwell M, Onipinla AK, Markandu ND, Cappuccio FP, Cook DG, Persu A, Corvol P, Jeunemaitre X, Carter ND, MacGregor GA. Association of hypertension with the T594 M mutation in β subunit of epithelial sodium channels in black people resident in London. Lancet. 1998;351:1388-1392.
51. Munroe PB, Strautnieks SS, Farrald M, Daniel HI, Lawson M, DeFreitas P, Fogarty P, Gardiner RM, Caulfield M. Absence of linkage of the epithelial sodium channel to hypertension in black Carribeans. Am J Hypertens. 1998;11:942-945.
52. + channel. Proc Natl Acad Sci U S A. 1997;94:9962-9966.
53. + channel in essential hypertension. J Hypertens. 1999; (In press).
54. Persu A, Barbry P, Houot A-M, Corvol P, Jeunemaitre X. Frequency of a polymorphism of the a subunit of the epithelial Na channel. Am J Hypertens 1998;11(4 part 2):6A. Abstract.
55. Baker E, Ireson NJ, Dong YB, Blackwood A, Sagnella GA, Carter ND, MacGregor GA. Increased sodium channel activity in black people with T5494 M epithelial sodium channel mutation: Third European Research Conference on Blood Pressure and Cardiovascular Disease. Hypertension 1998;32:810. Abstract.
56. Barlassina C, Citterio L, Bernardi L, Buzzi L, D'Amico M, Sciarrone T, Bianchi G. Genetics of renal mechanisms of primary hypertension: the role of adducin. J Hypertens. 1997;15:1567-1571.
57. Julier C, Delepine M, Keavney B, Terwilliger J, Davis S, Weeks DE, Bui T, Jeunemaitre X, Velho G, Froguel P, Ratcliffe P, Corvol P, Soubrier F, Lathrop GM. Genetic susceptibility for human familial essential hypertension in a region of homology with blood pressure linkage on rat chromosome 10. Hum Mol Genet. 1997;6:2077-2085.
58. Lodwick D, Kaiser MA, Harris J, Cumin F, Vincent M, Samani NJ. Analysis of the role of angiotensinogen in spontaneous hypertension. Hypertension. 1995;25:1245-1251.
59. Hübner N, Kreutz R, Takahashi S, Ganten D, Lindpaintner K. Unlike human hypertension, blood pressure in a hereditary hypertensive rat strain shows no linkage to the angiotensinogen locus. Hypertension. 1994;23: 797-801.
60. St Lezin E, Zhang L, Yang Y, Wang JM, Wang N, Qi N, Steadman JS, Liu W, Kren V, Zidek V, Krenova D, Churchill PC, Churchill MC, Pravenec M. Effect of chromosome 19 transfer on blood pressure in the spontaneously hypertensive rat. Hypertension. 1999;33:256-260.
61. Grunder S, Zagato L, Yagil C, Yagil Y, Sassard J, Rossier BC. Polymorphisms in the carboxy-terminus of the epithelial sodium channel in rat models for hypertension. J Hypertens. 1997;15:173-178.
62. Kreutz R, Struk B, Rubattu S, Hubner N, Szpirer J, Szpirer C, Ganten D, Lindpaintner K. Role of the a-, b-, and g-subunits of epithelial sodium channel in a model of polygenic hypertension. Hypertension. 1997;29: 131-136.
63. Smithies O, Kim HS. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci U S A. 1994;91:3612-3615.
64. Kim HS, Krege JH, Kluckman KD, Hagaman JR, Hodgin JB, Best CF, Jennette C, Coffman TM, Maeda N, Smithies O. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci U S A. 1995; 92:2735-2739.
65. Krege JH, Kim HS, Moyer JS, Jennette JC, Peng L, Hiller SK, Smithies O. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension. 1997;29:150-157.
66. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 1997;15:1579-1592.
67. O'Byrne S, Caulfield M. Genetics of hypertension: therapeutic implications. Drugs. 1998;56:203-214.
68. Hunt SC, Cook NR, Oberman A, Cutler JA, Hennekens CH, Altender PS, Walker WG, Whelton PK, Willials RR. Angiotensinogen genotype sodium reduction, weight loss, and prevention of hypertension. Hypertension. 1998;32:393-401.